Recombinant Therapeutic Antibodies and Proteins Market is Estimated To Witness High Growth Owing To Increasing Demand For Biologics
The recombinant therapeutic antibodies and proteins market is estimated to be valued at US$102 Bn in 2022 and is expected to exhibit a CAGR of 12.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.